Etonogestrel contraceptive implant-associated secondary anorgasmia.

Autor: Chapa HO; Obstetrics and Gynecology, Texas A&M College of Medicine, 8447 TX-47, Bryan, TX 77807. Electronic address: ChapaMD@Gmail.com., Ramirez A; Texas A&M University, Administration Building, 400 Bizzell St, College Station, TX 77843. Electronic address: AlexiyaRamirez@Yahoo.com., Dawson D; Obstetrics and Gynecology, Texas A&M College of Medicine, 8447 TX-47, Bryan, TX 77807. Electronic address: drdanieldawson@gmail.com.
Jazyk: angličtina
Zdroj: Contraception [Contraception] 2017 Oct; Vol. 96 (4), pp. 254-256. Date of Electronic Publication: 2017 Jun 27.
DOI: 10.1016/j.contraception.2017.06.008
Abstrakt: The etonogestrel contraceptive implant is a 4-cm radio-opaque subdermal rod, inserted in the nondominant arm, providing up to 3 years of continuous contraception. We describe a 21-year-old nulligravid, nondepressed female who experienced new-onset secondary anorgasmia 1 month after etonogestrel insertion. Off-label, oral use of bupropion and sildenafil did not restore orgasmic ability. Finally, 1 week after implant removal (4½ months after insertion), spontaneous return of orgasmic ability occurred. Anorgasmia after etonogestrel implant use is a rare adverse event; nonetheless, clinicians should be alert to its possibility.
Implication Statement: This report documents secondary anorgasmia in a nondepressed female temporally associated with etonogestrel implant insertion. Clinicians should be aware that this rare event can occur but is quickly reversible with implant removal.
(Copyright © 2017 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: